ES2407283T3 - Distracción de callo óseo artificial tridimensional - Google Patents
Distracción de callo óseo artificial tridimensional Download PDFInfo
- Publication number
- ES2407283T3 ES2407283T3 ES07818725T ES07818725T ES2407283T3 ES 2407283 T3 ES2407283 T3 ES 2407283T3 ES 07818725 T ES07818725 T ES 07818725T ES 07818725 T ES07818725 T ES 07818725T ES 2407283 T3 ES2407283 T3 ES 2407283T3
- Authority
- ES
- Spain
- Prior art keywords
- frame
- framework
- bone
- intermediate spaces
- fibers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 86
- 206010020649 Hyperkeratosis Diseases 0.000 title description 6
- 239000000463 material Substances 0.000 claims abstract description 139
- 239000000835 fiber Substances 0.000 claims abstract description 84
- 238000011069 regeneration method Methods 0.000 claims abstract description 19
- 230000008929 regeneration Effects 0.000 claims abstract description 18
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 238000011049 filling Methods 0.000 claims abstract description 6
- 229920003023 plastic Polymers 0.000 claims abstract description 6
- 239000004033 plastic Substances 0.000 claims abstract description 6
- 238000011084 recovery Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 42
- 239000011148 porous material Substances 0.000 claims description 25
- 230000010478 bone regeneration Effects 0.000 claims description 19
- 230000008569 process Effects 0.000 claims description 16
- 239000003292 glue Substances 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 11
- 229920000954 Polyglycolide Polymers 0.000 claims description 10
- 239000002131 composite material Substances 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 9
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 9
- 239000004633 polyglycolic acid Substances 0.000 claims description 9
- 239000004626 polylactic acid Substances 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 229920002732 Polyanhydride Polymers 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 5
- 108010035532 Collagen Proteins 0.000 claims description 5
- 229920001397 Poly-beta-hydroxybutyrate Polymers 0.000 claims description 5
- 229920000331 Polyhydroxybutyrate Polymers 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 5
- 229920001436 collagen Polymers 0.000 claims description 5
- 230000000035 biogenic effect Effects 0.000 claims description 4
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 claims description 4
- 102000009123 Fibrin Human genes 0.000 claims description 3
- 108010073385 Fibrin Proteins 0.000 claims description 3
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 3
- 229950003499 fibrin Drugs 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- 238000001125 extrusion Methods 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 53
- 230000007547 defect Effects 0.000 description 34
- 210000000963 osteoblast Anatomy 0.000 description 26
- 230000004048 modification Effects 0.000 description 22
- 238000012986 modification Methods 0.000 description 22
- 230000002950 deficient Effects 0.000 description 17
- 208000007536 Thrombosis Diseases 0.000 description 16
- 108090000765 processed proteins & peptides Proteins 0.000 description 15
- 239000011248 coating agent Substances 0.000 description 14
- 238000000576 coating method Methods 0.000 description 14
- 229920000642 polymer Polymers 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 238000006073 displacement reaction Methods 0.000 description 9
- 210000002950 fibroblast Anatomy 0.000 description 9
- 239000011257 shell material Substances 0.000 description 9
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 8
- 239000000316 bone substitute Substances 0.000 description 8
- 230000008602 contraction Effects 0.000 description 8
- 230000011164 ossification Effects 0.000 description 8
- 230000005540 biological transmission Effects 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 6
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 6
- 210000002744 extracellular matrix Anatomy 0.000 description 6
- 239000000017 hydrogel Substances 0.000 description 6
- 238000002513 implantation Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 210000005009 osteogenic cell Anatomy 0.000 description 5
- 102000016359 Fibronectins Human genes 0.000 description 4
- 108010067306 Fibronectins Proteins 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 230000000735 allogeneic effect Effects 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000007906 compression Methods 0.000 description 4
- 230000006835 compression Effects 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- -1 ethyl hydroxyl Chemical group 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 4
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000021164 cell adhesion Effects 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 210000002889 endothelial cell Anatomy 0.000 description 3
- 210000001650 focal adhesion Anatomy 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000009103 reabsorption Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- 102000006495 integrins Human genes 0.000 description 2
- 108010044426 integrins Proteins 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 230000002188 osteogenic effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 238000012876 topography Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920001710 Polyorthoester Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002965 anti-thrombogenic effect Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000002016 colloidosmotic effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 210000001608 connective tissue cell Anatomy 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000009799 cystectomy Methods 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000009442 healing mechanism Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920002627 poly(phosphazenes) Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 229920005594 polymer fiber Polymers 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 238000003980 solgel method Methods 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006047248A DE102006047248B4 (de) | 2006-10-06 | 2006-10-06 | Dreidimensionale künstliche Kallusdistraktion |
| DE102006047248 | 2006-10-06 | ||
| PCT/EP2007/008648 WO2008043484A2 (fr) | 2006-10-06 | 2007-10-05 | Séparation de callosité artificielle tridimensionnelle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2407283T3 true ES2407283T3 (es) | 2013-06-12 |
Family
ID=39154578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES07818725T Active ES2407283T3 (es) | 2006-10-06 | 2007-10-05 | Distracción de callo óseo artificial tridimensional |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8834577B2 (fr) |
| EP (1) | EP2079391B1 (fr) |
| JP (1) | JP5099650B2 (fr) |
| CN (1) | CN101610732B (fr) |
| DE (1) | DE102006047248B4 (fr) |
| ES (1) | ES2407283T3 (fr) |
| WO (1) | WO2008043484A2 (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040081704A1 (en) * | 1998-02-13 | 2004-04-29 | Centerpulse Biologics Inc. | Implantable putty material |
| US7771482B1 (en) | 2000-05-09 | 2010-08-10 | Ben-Zion Karmon | Method for tissue expansion and regeneration using bioresorbable inflatable devices |
| US20020114795A1 (en) * | 2000-12-22 | 2002-08-22 | Thorne Kevin J. | Composition and process for bone growth and repair |
| US7166133B2 (en) | 2002-06-13 | 2007-01-23 | Kensey Nash Corporation | Devices and methods for treating defects in the tissue of a living being |
| US7718616B2 (en) | 2006-12-21 | 2010-05-18 | Zimmer Orthobiologics, Inc. | Bone growth particles and osteoinductive composition thereof |
| DE102008064628A1 (de) * | 2008-03-15 | 2009-09-17 | Celgen Ag | Vorrichtung, umfassend ein Quellmittel und eine Ummantelung, zur künstlichen Kallusdistraktion |
| JP5382739B2 (ja) | 2008-03-15 | 2014-01-08 | セルゲン エージー | 膨張剤及びシースを備える人工的な仮骨延長デバイス |
| JP2010125156A (ja) * | 2008-11-28 | 2010-06-10 | Olympus Corp | 移植材とその製造方法 |
| CA2746534A1 (fr) * | 2008-12-31 | 2010-07-08 | Kci Licensing, Inc. | Systemes d'induction de debit de fluide pour stimuler la croissance tissulaire |
| DE102009042493B4 (de) | 2009-09-14 | 2016-07-21 | Celgen3D Ag | Granulatmischung, umfassend zwei verschiedene Granulate, zur künstlichen Kallusdistraktion |
| CN103313733A (zh) | 2010-11-15 | 2013-09-18 | 捷迈整形外科生物材料有限公司 | 骨空隙填充剂 |
| DE102011014789A1 (de) | 2011-03-14 | 2012-09-20 | Celgen Ag | Granulatmischung, umfassend zwei verschiedene Granulate, zur künstlichen Kallusdistraktion |
| US20160000974A1 (en) * | 2011-08-09 | 2016-01-07 | New Jersey Institute Of Technoloty | Composite Matrix for Bone Repair Applications |
| EP3316922A4 (fr) | 2015-06-30 | 2019-04-03 | University of South Florida | Implant ostéo-conducteur et ostéo-inducteur utilisé pour l'augmentation, la stabilisation, ou la reconstruction d'anomalies |
| IL243401A (en) | 2015-12-29 | 2017-12-31 | Zion Karmon Ben | Instruments and methods for lifting Schneider membrane |
| IL248472A0 (en) | 2016-10-13 | 2017-01-31 | Zion Karmon Ben | Devices for tissue growth |
| WO2019075584A1 (fr) * | 2017-10-17 | 2019-04-25 | Nicolas Perren | Dispositif d'induction non invasive de la déformation dynamique de tissu corporel pour la différenciation de cellules tissulaires |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0532582T3 (da) * | 1990-06-01 | 1996-01-29 | Du Pont | Sammensat ortopædisk implantat med varierende elasticitetsmodul |
| DE59108588D1 (de) * | 1991-08-07 | 1997-04-10 | Oscobal Ag | Endoprothese mit einem Metalldrahtwerk |
| WO1993015694A1 (fr) * | 1992-02-14 | 1993-08-19 | Board Of Regents, The University Of Texas System | Implant/support bio-erodable multi-phase et mode de fabrication et d'emploi |
| CZ295860B6 (cs) * | 1994-12-19 | 2005-11-16 | Sepitec Foundation | Způsob výroby konstrukčních prvků z termoplastů vyztužených vlákny a konstrukční prvek vyrobený tímto způsobem |
| DE19706667A1 (de) | 1997-02-20 | 1998-08-27 | Merck Patent Gmbh | Knochenersatzmaterial mit einer Oberflächenbelegung mit Peptiden mit RGD-Aminosäuresequenz |
| US6113599A (en) * | 1997-06-04 | 2000-09-05 | Kalpa Engineering, Inc. | Apparatus for internal mandibular distraction |
| US6350284B1 (en) * | 1998-09-14 | 2002-02-26 | Bionx Implants, Oy | Bioabsorbable, layered composite material for guided bone tissue regeneration |
| AU766735B2 (en) * | 1998-09-15 | 2003-10-23 | Isotis N.V. | Osteoinduction |
| US8137103B1 (en) * | 1999-05-13 | 2012-03-20 | University Of Connecticut | Implant system |
| US6280191B1 (en) * | 1999-09-03 | 2001-08-28 | Christopher B. Gordon | Distractor suitable for permanent implantation into bone |
| AU2000231660A1 (en) * | 2000-03-09 | 2001-09-17 | Syntacoll Ag | Multilayer collagen matrix for tissue reconstruction |
| EP2062548B1 (fr) * | 2000-05-29 | 2016-05-04 | CelGen AG | Membranes médicales destinées à la régénération d'os |
| US7052517B2 (en) * | 2000-10-24 | 2006-05-30 | Vita Special Purpose Corporation | Delivery device for biological composites and method of preparation thereof |
| FI20010540A0 (fi) * | 2001-03-16 | 2001-03-16 | Yli Urpo Antti | Komposiitti pehmyt- ja kovakudosvammojen korjaamiseksi ja mainitun komposiitin käyttö |
| US20050079159A1 (en) * | 2001-06-13 | 2005-04-14 | Massachusetts Instiute Of Technology | In vivo bioreactors |
| IL144446A0 (en) * | 2001-07-19 | 2002-05-23 | Prochon Biotech Ltd | Plasma protein matrices and methods for their preparation |
| US6758673B2 (en) * | 2001-12-05 | 2004-07-06 | Ofir Fromovich | Periosteal distraction |
| US20050118236A1 (en) * | 2002-12-03 | 2005-06-02 | Gentis Inc. | Bioactive, resorbable scaffolds for tissue engineering |
| JP4717336B2 (ja) * | 2003-08-06 | 2011-07-06 | グンゼ株式会社 | 骨再生用基材およびその製造法 |
| US20050074437A1 (en) * | 2003-10-06 | 2005-04-07 | Domonkos Horvath | Device for the regeneration of tissue, specifically bone regeneration by means of callus distraction |
| US7723395B2 (en) * | 2004-04-29 | 2010-05-25 | Kensey Nash Corporation | Compressed porous materials suitable for implant |
| JP4915004B2 (ja) * | 2004-03-22 | 2012-04-11 | 公益財団法人新産業創造研究機構 | 生分解性樹脂複合材料により構成される組織再生用足場（スカフォールド） |
| DE102004045410A1 (de) * | 2004-09-15 | 2006-03-30 | Glatt Gmbh | Knochenersatzimplantat für human- und veterinärmedizinische Anwendungen |
| WO2006034365A2 (fr) * | 2004-09-21 | 2006-03-30 | Massachusetts Institute Of Technology | Squelette a gradient et ses procedes de production |
| WO2006088866A2 (fr) * | 2005-02-14 | 2006-08-24 | Indiana University Research And Technology Corporation | Support porteur biodegradable pour regeneration osseuse |
-
2006
- 2006-10-06 DE DE102006047248A patent/DE102006047248B4/de not_active Expired - Fee Related
-
2007
- 2007-10-05 ES ES07818725T patent/ES2407283T3/es active Active
- 2007-10-05 EP EP07818725A patent/EP2079391B1/fr not_active Not-in-force
- 2007-10-05 US US12/444,367 patent/US8834577B2/en not_active Expired - Fee Related
- 2007-10-05 WO PCT/EP2007/008648 patent/WO2008043484A2/fr not_active Ceased
- 2007-10-05 JP JP2009530808A patent/JP5099650B2/ja not_active Expired - Fee Related
- 2007-10-05 CN CN2007800374012A patent/CN101610732B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010505480A (ja) | 2010-02-25 |
| US20100049330A1 (en) | 2010-02-25 |
| DE102006047248B4 (de) | 2012-05-31 |
| DE102006047248A1 (de) | 2008-04-10 |
| EP2079391A2 (fr) | 2009-07-22 |
| EP2079391B1 (fr) | 2013-02-27 |
| WO2008043484A2 (fr) | 2008-04-17 |
| CN101610732B (zh) | 2013-05-01 |
| US8834577B2 (en) | 2014-09-16 |
| WO2008043484A3 (fr) | 2008-05-29 |
| JP5099650B2 (ja) | 2012-12-19 |
| CN101610732A (zh) | 2009-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2407283T3 (es) | Distracción de callo óseo artificial tridimensional | |
| Del Bakhshayesh et al. | An overview of advanced biocompatible and biomimetic materials for creation of replacement structures in the musculoskeletal systems: focusing on cartilage tissue engineering | |
| ES2338464T3 (es) | Material compuesto, especialmente para uso medico, y procedimiento para producir el material. | |
| ES2700677T3 (es) | Composiciones para implante óseo que en un principio puede deformarse plásticamente | |
| US6991652B2 (en) | Tissue engineering composite | |
| ES2393403T3 (es) | Composición biocompatible para reemplazar o regenerar tejidos | |
| ES2877181T3 (es) | Reparación de cartílago articular | |
| JP5406915B2 (ja) | 生体適合性インプラント | |
| ES2424146T3 (es) | Canal guía de nervios | |
| ES2315223T3 (es) | Crecimiento celular. | |
| US20190022273A1 (en) | Devices and compositions and methods of use thereof | |
| Caridade et al. | Engineering membranes for bone regeneration | |
| Cao et al. | Functional hydrogel interfaces for cartilage and bone regeneration | |
| ES2563240T3 (es) | Dispositivo médico flocado y métodos para la fabricación del dispositivo | |
| US20130195955A1 (en) | Implants Containing BMP-7 | |
| ES2336452T3 (es) | Material composite que contiene hidrogel, producido por precipitacion de una base solida desencadenada electricamente. | |
| BR112020022387A2 (pt) | composições de material para bioarcabouço | |
| Santos Jr | Bioresorbable polymers for tissue engineering | |
| US9050190B2 (en) | Device comprising a swelling agent and sheathing for artificial callus distraction | |
| US20140005794A1 (en) | Granulate mixture comprising two different granulates for artificial callus distraction | |
| ES2975538T3 (es) | Método para preparar un armazón tridimensional para uso médico | |
| US9144582B2 (en) | Granulated material mixture comprising two different granulated materials for artificial callus distraction | |
| Hofmann et al. | Bioactive scaffolds for the controlled formation of complex skeletal tissues | |
| Darling et al. | Bioactive scaffold design for articular cartilage engineering | |
| Sheikh et al. | Injectable Hydrogels for Cartilage and Bone Regeneration: Material Properties, Delivery Strategies, and Clinical Applications |